内皮功能障碍的病理机制和临床研究进展
Zhuoran Wang1, Yuqiao Yang1, Quan Wang1
1Department of Anesthesiology, The First Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, China.
Frontiers in cardiovascular medicine
|February 20, 2026
概括
内皮功能障碍 (ED) 是心血管和代谢疾病的关键因素,涉及分子变化,如减少氧化和氧化应激. 这份审查详细介绍了ED的细节.
科学领域:
- 心血管研究研究心血管研究
- 内皮细胞生物学 内皮细胞生物学
- 代谢障碍 代谢障碍 代谢障碍
背景情况:
- 内皮功能障碍 (ED) 越来越被认为是心血管和代谢疾病的中心病理机制.
- 最近的研究强调了它的重要作用,需要全面理解.
研究的目的:
- 提供内皮功能障碍的详细概述,包括其定义,分子机制和相关条件.
- 探索当前和新兴的治疗策略来管理ED.
- 为诊断,预防和治疗提供实用指南.
主要方法:
- 关于内皮功能障碍的基础和临床研究的综合文献综述.
- 分子机制,临床关联,生物标志物和治疗干预的分析.
- 整合最近的科学发现和临床发现.
主要成果:
- 勃起障碍涉及降低氧化生物可用性,氧化应激,炎症和内皮-介质酶过渡等机制.
- 勃起障碍与糖尿病,动脉样硬化,脑血管疾病和阻塞性睡眠呼吸暂停有关.
- 讨论了各种生物标志物和治疗策略,包括小分子,干细胞和基因疗法.
结论:
- 对ED的机制和临床影响的彻底理解对于有效的管理至关重要.
- 这一审查建立了诊断,预防和治疗ED的框架.
- 整合研究结果为医疗保健专业人员提供了实际指导方针.
相关概念视频
Coronary Artery Disease II: Pathophysiology
670
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
670
Coronary Artery Disease I: Introduction
1.2K
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.2K
Peripheral Artery Disease I: Introduction
426
Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
426
Heart Failure II: Pathophysiology
1.1K
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.1K
Atherosclerosis I: Introduction
1.5K
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
1.5K
Regulation of Angiogenesis and Blood Supply
3.7K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
3.7K


